nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—VDR—breast cancer	0.298	0.778	CbGaD
Paricalcitol—UGT1A4—Tamoxifen—breast cancer	0.155	0.462	CbGbCtD
Paricalcitol—CYP3A4—breast cancer	0.085	0.222	CbGaD
Paricalcitol—CYP3A4—Exemestane—breast cancer	0.024	0.0715	CbGbCtD
Paricalcitol—CYP3A4—Letrozole—breast cancer	0.0204	0.0608	CbGbCtD
Paricalcitol—CYP3A4—Anastrozole—breast cancer	0.0182	0.0542	CbGbCtD
Paricalcitol—CYP3A4—Toremifene—breast cancer	0.0166	0.0496	CbGbCtD
Paricalcitol—CYP3A4—Fulvestrant—breast cancer	0.0155	0.0461	CbGbCtD
Paricalcitol—CYP3A4—Thiotepa—breast cancer	0.0138	0.0411	CbGbCtD
Paricalcitol—CYP3A4—Ixabepilone—breast cancer	0.0126	0.0376	CbGbCtD
Paricalcitol—CYP3A4—Lapatinib—breast cancer	0.0121	0.0362	CbGbCtD
Paricalcitol—CYP3A4—Raloxifene—breast cancer	0.0092	0.0274	CbGbCtD
Paricalcitol—CYP3A4—Vinorelbine—breast cancer	0.00674	0.0201	CbGbCtD
Paricalcitol—CYP3A4—Tamoxifen—breast cancer	0.00608	0.0181	CbGbCtD
Paricalcitol—CYP3A4—Mitoxantrone—breast cancer	0.00593	0.0177	CbGbCtD
Paricalcitol—CYP3A4—Paclitaxel—breast cancer	0.00473	0.0141	CbGbCtD
Paricalcitol—CYP3A4—Irinotecan—breast cancer	0.00467	0.0139	CbGbCtD
Paricalcitol—CYP3A4—Vinblastine—breast cancer	0.00415	0.0124	CbGbCtD
Paricalcitol—CYP3A4—Docetaxel—breast cancer	0.00342	0.0102	CbGbCtD
Paricalcitol—CYP3A4—Doxorubicin—breast cancer	0.00255	0.00759	CbGbCtD
Paricalcitol—VDR—mammary gland—breast cancer	0.00164	0.104	CbGeAlD
Paricalcitol—CYP24A1—endometrium—breast cancer	0.00149	0.0941	CbGeAlD
Paricalcitol—VDR—nipple—breast cancer	0.00136	0.0858	CbGeAlD
Paricalcitol—CYP24A1—female reproductive system—breast cancer	0.00123	0.078	CbGeAlD
Paricalcitol—UGT1A4—endocrine gland—breast cancer	0.00104	0.066	CbGeAlD
Paricalcitol—CYP24A1—endocrine gland—breast cancer	0.00104	0.066	CbGeAlD
Paricalcitol—VDR—epithelium—breast cancer	0.000914	0.0578	CbGeAlD
Paricalcitol—VDR—skin of body—breast cancer	0.00087	0.055	CbGeAlD
Paricalcitol—Dihydrotachysterol—VDR—breast cancer	0.000777	0.188	CrCbGaD
Paricalcitol—VDR—uterus—breast cancer	0.000755	0.0478	CbGeAlD
Paricalcitol—VDR—pituitary gland—breast cancer	0.000742	0.0469	CbGeAlD
Paricalcitol—VDR—adipose tissue—breast cancer	0.000739	0.0467	CbGeAlD
Paricalcitol—VDR—female reproductive system—breast cancer	0.000679	0.0429	CbGeAlD
Paricalcitol—VDR—adrenal gland—breast cancer	0.000663	0.0419	CbGeAlD
Paricalcitol—VDR—bone marrow—breast cancer	0.000641	0.0405	CbGeAlD
Paricalcitol—VDR—female gonad—breast cancer	0.000618	0.0391	CbGeAlD
Paricalcitol—VDR—endocrine gland—breast cancer	0.000575	0.0363	CbGeAlD
Paricalcitol—Alfacalcidol—VDR—breast cancer	0.000501	0.121	CrCbGaD
Paricalcitol—Calcipotriol—VDR—breast cancer	0.000501	0.121	CrCbGaD
Paricalcitol—Calcidiol—VDR—breast cancer	0.000501	0.121	CrCbGaD
Paricalcitol—Calcitriol—VDR—breast cancer	0.000447	0.108	CrCbGaD
Paricalcitol—VDR—lymph node—breast cancer	0.000397	0.0251	CbGeAlD
Paricalcitol—Ergocalciferol—VDR—breast cancer	0.000357	0.0864	CrCbGaD
Paricalcitol—Cholecalciferol—VDR—breast cancer	0.000271	0.0655	CrCbGaD
Paricalcitol—Ergocalciferol—AR—breast cancer	0.000259	0.0627	CrCbGaD
Paricalcitol—CYP3A4—female reproductive system—breast cancer	0.000227	0.0143	CbGeAlD
Paricalcitol—CYP3A4—endocrine gland—breast cancer	0.000192	0.0121	CbGeAlD
Paricalcitol—Calcitriol—CYP3A4—breast cancer	0.000127	0.0308	CrCbGaD
Paricalcitol—Cholecalciferol—CYP1A1—breast cancer	0.000121	0.0292	CrCbGaD
Paricalcitol—Ergocalciferol—CYP3A4—breast cancer	0.000102	0.0246	CrCbGaD
Paricalcitol—Cholecalciferol—CYP2D6—breast cancer	8.99e-05	0.0218	CrCbGaD
Paricalcitol—Cholecalciferol—CYP3A4—breast cancer	7.71e-05	0.0187	CrCbGaD
Paricalcitol—Headache—Gemcitabine—breast cancer	2.81e-05	0.000173	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Capecitabine—breast cancer	2.81e-05	0.000173	CcSEcCtD
Paricalcitol—Cardiac disorder—Epirubicin—breast cancer	2.8e-05	0.000172	CcSEcCtD
Paricalcitol—Vomiting—Fluorouracil—breast cancer	2.8e-05	0.000172	CcSEcCtD
Paricalcitol—Dyspepsia—Docetaxel—breast cancer	2.8e-05	0.000172	CcSEcCtD
Paricalcitol—Insomnia—Capecitabine—breast cancer	2.79e-05	0.000171	CcSEcCtD
Paricalcitol—Hypoaesthesia—Doxorubicin—breast cancer	2.78e-05	0.000171	CcSEcCtD
Paricalcitol—Rash—Fluorouracil—breast cancer	2.78e-05	0.000171	CcSEcCtD
Paricalcitol—Dermatitis—Fluorouracil—breast cancer	2.78e-05	0.000171	CcSEcCtD
Paricalcitol—Pharyngitis—Doxorubicin—breast cancer	2.77e-05	0.000171	CcSEcCtD
Paricalcitol—Paraesthesia—Capecitabine—breast cancer	2.77e-05	0.00017	CcSEcCtD
Paricalcitol—Decreased appetite—Docetaxel—breast cancer	2.77e-05	0.00017	CcSEcCtD
Paricalcitol—Hypersensitivity—Paclitaxel—breast cancer	2.77e-05	0.00017	CcSEcCtD
Paricalcitol—Headache—Fluorouracil—breast cancer	2.76e-05	0.00017	CcSEcCtD
Paricalcitol—Urinary tract disorder—Doxorubicin—breast cancer	2.76e-05	0.00017	CcSEcCtD
Paricalcitol—Oedema peripheral—Doxorubicin—breast cancer	2.75e-05	0.000169	CcSEcCtD
Paricalcitol—Dysgeusia—Methotrexate—breast cancer	2.75e-05	0.000169	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Docetaxel—breast cancer	2.75e-05	0.000169	CcSEcCtD
Paricalcitol—Connective tissue disorder—Doxorubicin—breast cancer	2.75e-05	0.000169	CcSEcCtD
Paricalcitol—Dyspnoea—Capecitabine—breast cancer	2.75e-05	0.000169	CcSEcCtD
Paricalcitol—Fatigue—Docetaxel—breast cancer	2.74e-05	0.000169	CcSEcCtD
Paricalcitol—Angiopathy—Epirubicin—breast cancer	2.74e-05	0.000169	CcSEcCtD
Paricalcitol—Urethral disorder—Doxorubicin—breast cancer	2.74e-05	0.000169	CcSEcCtD
Paricalcitol—Nausea—Irinotecan—breast cancer	2.73e-05	0.000168	CcSEcCtD
Paricalcitol—Nausea—Mitoxantrone—breast cancer	2.73e-05	0.000168	CcSEcCtD
Paricalcitol—Immune system disorder—Epirubicin—breast cancer	2.73e-05	0.000168	CcSEcCtD
Paricalcitol—Mediastinal disorder—Epirubicin—breast cancer	2.72e-05	0.000167	CcSEcCtD
Paricalcitol—Pain—Docetaxel—breast cancer	2.72e-05	0.000167	CcSEcCtD
Paricalcitol—Constipation—Docetaxel—breast cancer	2.72e-05	0.000167	CcSEcCtD
Paricalcitol—Back pain—Methotrexate—breast cancer	2.72e-05	0.000167	CcSEcCtD
Paricalcitol—Dyspepsia—Capecitabine—breast cancer	2.71e-05	0.000167	CcSEcCtD
Paricalcitol—Chills—Epirubicin—breast cancer	2.71e-05	0.000167	CcSEcCtD
Paricalcitol—Arrhythmia—Epirubicin—breast cancer	2.7e-05	0.000166	CcSEcCtD
Paricalcitol—Asthenia—Paclitaxel—breast cancer	2.69e-05	0.000166	CcSEcCtD
Paricalcitol—Decreased appetite—Capecitabine—breast cancer	2.68e-05	0.000165	CcSEcCtD
Paricalcitol—Alopecia—Epirubicin—breast cancer	2.67e-05	0.000164	CcSEcCtD
Paricalcitol—Nausea—Gemcitabine—breast cancer	2.66e-05	0.000164	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Capecitabine—breast cancer	2.66e-05	0.000164	CcSEcCtD
Paricalcitol—Fatigue—Capecitabine—breast cancer	2.66e-05	0.000163	CcSEcCtD
Paricalcitol—Pruritus—Paclitaxel—breast cancer	2.66e-05	0.000163	CcSEcCtD
Paricalcitol—Mental disorder—Epirubicin—breast cancer	2.65e-05	0.000163	CcSEcCtD
Paricalcitol—Constipation—Capecitabine—breast cancer	2.63e-05	0.000162	CcSEcCtD
Paricalcitol—Pain—Capecitabine—breast cancer	2.63e-05	0.000162	CcSEcCtD
Paricalcitol—Malnutrition—Epirubicin—breast cancer	2.63e-05	0.000162	CcSEcCtD
Paricalcitol—Feeling abnormal—Docetaxel—breast cancer	2.62e-05	0.000161	CcSEcCtD
Paricalcitol—Nausea—Fluorouracil—breast cancer	2.62e-05	0.000161	CcSEcCtD
Paricalcitol—Eye disorder—Doxorubicin—breast cancer	2.61e-05	0.000161	CcSEcCtD
Paricalcitol—Ill-defined disorder—Methotrexate—breast cancer	2.61e-05	0.00016	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Docetaxel—breast cancer	2.6e-05	0.00016	CcSEcCtD
Paricalcitol—Anaemia—Methotrexate—breast cancer	2.6e-05	0.00016	CcSEcCtD
Paricalcitol—Cardiac disorder—Doxorubicin—breast cancer	2.59e-05	0.00016	CcSEcCtD
Paricalcitol—Tension—Epirubicin—breast cancer	2.58e-05	0.000159	CcSEcCtD
Paricalcitol—Dysgeusia—Epirubicin—breast cancer	2.58e-05	0.000158	CcSEcCtD
Paricalcitol—Diarrhoea—Paclitaxel—breast cancer	2.57e-05	0.000158	CcSEcCtD
Paricalcitol—Nervousness—Epirubicin—breast cancer	2.55e-05	0.000157	CcSEcCtD
Paricalcitol—Back pain—Epirubicin—breast cancer	2.54e-05	0.000156	CcSEcCtD
Paricalcitol—Feeling abnormal—Capecitabine—breast cancer	2.54e-05	0.000156	CcSEcCtD
Paricalcitol—Angiopathy—Doxorubicin—breast cancer	2.54e-05	0.000156	CcSEcCtD
Paricalcitol—Malaise—Methotrexate—breast cancer	2.53e-05	0.000156	CcSEcCtD
Paricalcitol—Muscle spasms—Epirubicin—breast cancer	2.53e-05	0.000155	CcSEcCtD
Paricalcitol—Immune system disorder—Doxorubicin—breast cancer	2.52e-05	0.000155	CcSEcCtD
Paricalcitol—Vertigo—Methotrexate—breast cancer	2.52e-05	0.000155	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Capecitabine—breast cancer	2.52e-05	0.000155	CcSEcCtD
Paricalcitol—Mediastinal disorder—Doxorubicin—breast cancer	2.52e-05	0.000155	CcSEcCtD
Paricalcitol—Abdominal pain—Docetaxel—breast cancer	2.52e-05	0.000155	CcSEcCtD
Paricalcitol—Body temperature increased—Docetaxel—breast cancer	2.52e-05	0.000155	CcSEcCtD
Paricalcitol—Leukopenia—Methotrexate—breast cancer	2.52e-05	0.000155	CcSEcCtD
Paricalcitol—Chills—Doxorubicin—breast cancer	2.51e-05	0.000154	CcSEcCtD
Paricalcitol—Arrhythmia—Doxorubicin—breast cancer	2.5e-05	0.000154	CcSEcCtD
Paricalcitol—Dizziness—Paclitaxel—breast cancer	2.48e-05	0.000153	CcSEcCtD
Paricalcitol—Alopecia—Doxorubicin—breast cancer	2.47e-05	0.000152	CcSEcCtD
Paricalcitol—Cough—Methotrexate—breast cancer	2.45e-05	0.000151	CcSEcCtD
Paricalcitol—Mental disorder—Doxorubicin—breast cancer	2.45e-05	0.000151	CcSEcCtD
Paricalcitol—Urticaria—Capecitabine—breast cancer	2.45e-05	0.000151	CcSEcCtD
Paricalcitol—Ill-defined disorder—Epirubicin—breast cancer	2.44e-05	0.00015	CcSEcCtD
Paricalcitol—Body temperature increased—Capecitabine—breast cancer	2.44e-05	0.00015	CcSEcCtD
Paricalcitol—Abdominal pain—Capecitabine—breast cancer	2.44e-05	0.00015	CcSEcCtD
Paricalcitol—Malnutrition—Doxorubicin—breast cancer	2.43e-05	0.00015	CcSEcCtD
Paricalcitol—Anaemia—Epirubicin—breast cancer	2.43e-05	0.000149	CcSEcCtD
Paricalcitol—Agitation—Epirubicin—breast cancer	2.42e-05	0.000149	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—MTR—breast cancer	2.4e-05	0.000243	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CPT1A—breast cancer	2.4e-05	0.000243	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ABCG2—breast cancer	2.4e-05	0.000243	CbGpPWpGaD
Paricalcitol—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—breast cancer	2.4e-05	0.000243	CbGpPWpGaD
Paricalcitol—Chest pain—Methotrexate—breast cancer	2.39e-05	0.000147	CcSEcCtD
Paricalcitol—Arthralgia—Methotrexate—breast cancer	2.39e-05	0.000147	CcSEcCtD
Paricalcitol—Myalgia—Methotrexate—breast cancer	2.39e-05	0.000147	CcSEcCtD
Paricalcitol—Tension—Doxorubicin—breast cancer	2.39e-05	0.000147	CcSEcCtD
Paricalcitol—Vomiting—Paclitaxel—breast cancer	2.39e-05	0.000147	CcSEcCtD
Paricalcitol—Dysgeusia—Doxorubicin—breast cancer	2.38e-05	0.000147	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—IDH1—breast cancer	2.38e-05	0.000241	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GSTA1—breast cancer	2.38e-05	0.000241	CbGpPWpGaD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.38e-05	0.000146	CcSEcCtD
Paricalcitol—Malaise—Epirubicin—breast cancer	2.37e-05	0.000146	CcSEcCtD
Paricalcitol—CYP3A4—Metapathway biotransformation—GSTA4—breast cancer	2.37e-05	0.00024	CbGpPWpGaD
Paricalcitol—Rash—Paclitaxel—breast cancer	2.37e-05	0.000146	CcSEcCtD
Paricalcitol—Dermatitis—Paclitaxel—breast cancer	2.36e-05	0.000145	CcSEcCtD
Paricalcitol—Discomfort—Methotrexate—breast cancer	2.36e-05	0.000145	CcSEcCtD
Paricalcitol—Nervousness—Doxorubicin—breast cancer	2.36e-05	0.000145	CcSEcCtD
Paricalcitol—Vertigo—Epirubicin—breast cancer	2.36e-05	0.000145	CcSEcCtD
Paricalcitol—Syncope—Epirubicin—breast cancer	2.36e-05	0.000145	CcSEcCtD
Paricalcitol—Leukopenia—Epirubicin—breast cancer	2.35e-05	0.000145	CcSEcCtD
Paricalcitol—Back pain—Doxorubicin—breast cancer	2.35e-05	0.000145	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—HPGDS—breast cancer	2.35e-05	0.000239	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NAT2—breast cancer	2.35e-05	0.000239	CbGpPWpGaD
Paricalcitol—Headache—Paclitaxel—breast cancer	2.35e-05	0.000145	CcSEcCtD
Paricalcitol—Hypersensitivity—Docetaxel—breast cancer	2.34e-05	0.000144	CcSEcCtD
Paricalcitol—CYP3A4—Biological oxidations—GSTA2—breast cancer	2.34e-05	0.000237	CbGpPWpGaD
Paricalcitol—Muscle spasms—Doxorubicin—breast cancer	2.34e-05	0.000144	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—HBA1—breast cancer	2.34e-05	0.000237	CbGpPWpGaD
Paricalcitol—Palpitations—Epirubicin—breast cancer	2.32e-05	0.000143	CcSEcCtD
Paricalcitol—Confusional state—Methotrexate—breast cancer	2.31e-05	0.000142	CcSEcCtD
Paricalcitol—CYP3A4—Biological oxidations—SULT1A1—breast cancer	2.31e-05	0.000235	CbGpPWpGaD
Paricalcitol—Loss of consciousness—Epirubicin—breast cancer	2.31e-05	0.000142	CcSEcCtD
Paricalcitol—CYP3A4—Metapathway biotransformation—GPX2—breast cancer	2.31e-05	0.000234	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—PGR—breast cancer	2.3e-05	0.000234	CbGpPWpGaD
Paricalcitol—Cough—Epirubicin—breast cancer	2.29e-05	0.000141	CcSEcCtD
Paricalcitol—Asthenia—Docetaxel—breast cancer	2.28e-05	0.00014	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—GSTT1—breast cancer	2.28e-05	0.000231	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ACHE—breast cancer	2.28e-05	0.000231	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—GPX4—breast cancer	2.28e-05	0.000231	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—SULT1A1—breast cancer	2.28e-05	0.000231	CbGpPWpGaD
Paricalcitol—Infection—Methotrexate—breast cancer	2.28e-05	0.00014	CcSEcCtD
Paricalcitol—Hypertension—Epirubicin—breast cancer	2.27e-05	0.00014	CcSEcCtD
Paricalcitol—Hypersensitivity—Capecitabine—breast cancer	2.27e-05	0.00014	CcSEcCtD
Paricalcitol—VDR—Gene Expression—DNMT1—breast cancer	2.26e-05	0.000229	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—GSTA1—breast cancer	2.26e-05	0.000229	CbGpPWpGaD
Paricalcitol—Ill-defined disorder—Doxorubicin—breast cancer	2.26e-05	0.000139	CcSEcCtD
Paricalcitol—Pruritus—Docetaxel—breast cancer	2.25e-05	0.000138	CcSEcCtD
Paricalcitol—Nervous system disorder—Methotrexate—breast cancer	2.25e-05	0.000138	CcSEcCtD
Paricalcitol—Anaemia—Doxorubicin—breast cancer	2.25e-05	0.000138	CcSEcCtD
Paricalcitol—Chest pain—Epirubicin—breast cancer	2.24e-05	0.000138	CcSEcCtD
Paricalcitol—Arthralgia—Epirubicin—breast cancer	2.24e-05	0.000138	CcSEcCtD
Paricalcitol—Myalgia—Epirubicin—breast cancer	2.24e-05	0.000138	CcSEcCtD
Paricalcitol—Agitation—Doxorubicin—breast cancer	2.24e-05	0.000138	CcSEcCtD
Paricalcitol—CYP3A4—Biological oxidations—NAT2—breast cancer	2.23e-05	0.000227	CbGpPWpGaD
Paricalcitol—Anxiety—Epirubicin—breast cancer	2.23e-05	0.000137	CcSEcCtD
Paricalcitol—Nausea—Paclitaxel—breast cancer	2.23e-05	0.000137	CcSEcCtD
Paricalcitol—Skin disorder—Methotrexate—breast cancer	2.23e-05	0.000137	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.22e-05	0.000137	CcSEcCtD
Paricalcitol—VDR—Gene Expression—NCOA2—breast cancer	2.22e-05	0.000225	CbGpPWpGaD
Paricalcitol—Hyperhidrosis—Methotrexate—breast cancer	2.22e-05	0.000136	CcSEcCtD
Paricalcitol—Discomfort—Epirubicin—breast cancer	2.21e-05	0.000136	CcSEcCtD
Paricalcitol—Asthenia—Capecitabine—breast cancer	2.21e-05	0.000136	CcSEcCtD
Paricalcitol—CYP3A4—Metapathway biotransformation—NAT2—breast cancer	2.2e-05	0.000223	CbGpPWpGaD
Paricalcitol—Malaise—Doxorubicin—breast cancer	2.19e-05	0.000135	CcSEcCtD
Paricalcitol—Dry mouth—Epirubicin—breast cancer	2.19e-05	0.000135	CcSEcCtD
Paricalcitol—VDR—Gene Expression—EZH2—breast cancer	2.19e-05	0.000222	CbGpPWpGaD
Paricalcitol—Vertigo—Doxorubicin—breast cancer	2.19e-05	0.000134	CcSEcCtD
Paricalcitol—Anorexia—Methotrexate—breast cancer	2.19e-05	0.000134	CcSEcCtD
Paricalcitol—Syncope—Doxorubicin—breast cancer	2.18e-05	0.000134	CcSEcCtD
Paricalcitol—Pruritus—Capecitabine—breast cancer	2.18e-05	0.000134	CcSEcCtD
Paricalcitol—Leukopenia—Doxorubicin—breast cancer	2.18e-05	0.000134	CcSEcCtD
Paricalcitol—Diarrhoea—Docetaxel—breast cancer	2.18e-05	0.000134	CcSEcCtD
Paricalcitol—Confusional state—Epirubicin—breast cancer	2.16e-05	0.000133	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—CYP17A1—breast cancer	2.16e-05	0.000219	CbGpPWpGaD
Paricalcitol—Palpitations—Doxorubicin—breast cancer	2.15e-05	0.000132	CcSEcCtD
Paricalcitol—Oedema—Epirubicin—breast cancer	2.15e-05	0.000132	CcSEcCtD
Paricalcitol—Hypotension—Methotrexate—breast cancer	2.14e-05	0.000132	CcSEcCtD
Paricalcitol—VDR—Gene Expression—NOTCH3—breast cancer	2.14e-05	0.000217	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—PARP1—breast cancer	2.14e-05	0.000217	CbGpPWpGaD
Paricalcitol—Loss of consciousness—Doxorubicin—breast cancer	2.14e-05	0.000132	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—ENO1—breast cancer	2.14e-05	0.000217	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PTGS1—breast cancer	2.14e-05	0.000217	CbGpPWpGaD
Paricalcitol—Infection—Epirubicin—breast cancer	2.13e-05	0.000131	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.13e-05	0.000216	CbGpPWpGaD
Paricalcitol—Cough—Doxorubicin—breast cancer	2.12e-05	0.000131	CcSEcCtD
Paricalcitol—Shock—Epirubicin—breast cancer	2.11e-05	0.00013	CcSEcCtD
Paricalcitol—Diarrhoea—Capecitabine—breast cancer	2.11e-05	0.00013	CcSEcCtD
Paricalcitol—Nervous system disorder—Epirubicin—breast cancer	2.1e-05	0.000129	CcSEcCtD
Paricalcitol—Dizziness—Docetaxel—breast cancer	2.1e-05	0.000129	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.1e-05	0.000213	CbGpPWpGaD
Paricalcitol—Hypertension—Doxorubicin—breast cancer	2.1e-05	0.000129	CcSEcCtD
Paricalcitol—VDR—Generic Transcription Pathway—SERPINE1—breast cancer	2.1e-05	0.000213	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CYP2D6—breast cancer	2.1e-05	0.000213	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—RPS6—breast cancer	2.09e-05	0.000212	CbGpPWpGaD
Paricalcitol—Musculoskeletal discomfort—Methotrexate—breast cancer	2.09e-05	0.000129	CcSEcCtD
Paricalcitol—Skin disorder—Epirubicin—breast cancer	2.08e-05	0.000128	CcSEcCtD
Paricalcitol—Hyperhidrosis—Epirubicin—breast cancer	2.07e-05	0.000128	CcSEcCtD
Paricalcitol—Insomnia—Methotrexate—breast cancer	2.07e-05	0.000128	CcSEcCtD
Paricalcitol—Myalgia—Doxorubicin—breast cancer	2.07e-05	0.000127	CcSEcCtD
Paricalcitol—Chest pain—Doxorubicin—breast cancer	2.07e-05	0.000127	CcSEcCtD
Paricalcitol—Arthralgia—Doxorubicin—breast cancer	2.07e-05	0.000127	CcSEcCtD
Paricalcitol—Anxiety—Doxorubicin—breast cancer	2.06e-05	0.000127	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—DPYD—breast cancer	2.06e-05	0.000209	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—MED12—breast cancer	2.06e-05	0.000209	CbGpPWpGaD
Paricalcitol—Paraesthesia—Methotrexate—breast cancer	2.06e-05	0.000127	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—NCOA2—breast cancer	2.06e-05	0.000209	CbGpPWpGaD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.06e-05	0.000127	CcSEcCtD
Paricalcitol—Discomfort—Doxorubicin—breast cancer	2.05e-05	0.000126	CcSEcCtD
Paricalcitol—Anorexia—Epirubicin—breast cancer	2.05e-05	0.000126	CcSEcCtD
Paricalcitol—Dyspnoea—Methotrexate—breast cancer	2.04e-05	0.000126	CcSEcCtD
Paricalcitol—Somnolence—Methotrexate—breast cancer	2.04e-05	0.000125	CcSEcCtD
Paricalcitol—Dizziness—Capecitabine—breast cancer	2.04e-05	0.000125	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—ALDOA—breast cancer	2.03e-05	0.000206	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—ESR2—breast cancer	2.03e-05	0.000206	CbGpPWpGaD
Paricalcitol—Dry mouth—Doxorubicin—breast cancer	2.03e-05	0.000125	CcSEcCtD
Paricalcitol—Vomiting—Docetaxel—breast cancer	2.02e-05	0.000124	CcSEcCtD
Paricalcitol—Dyspepsia—Methotrexate—breast cancer	2.02e-05	0.000124	CcSEcCtD
Paricalcitol—Rash—Docetaxel—breast cancer	2.01e-05	0.000123	CcSEcCtD
Paricalcitol—Hypotension—Epirubicin—breast cancer	2.01e-05	0.000123	CcSEcCtD
Paricalcitol—Dermatitis—Docetaxel—breast cancer	2e-05	0.000123	CcSEcCtD
Paricalcitol—Confusional state—Doxorubicin—breast cancer	2e-05	0.000123	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—FASN—breast cancer	2e-05	0.000202	CbGpPWpGaD
Paricalcitol—Decreased appetite—Methotrexate—breast cancer	1.99e-05	0.000123	CcSEcCtD
Paricalcitol—Headache—Docetaxel—breast cancer	1.99e-05	0.000123	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—BCHE—breast cancer	1.99e-05	0.000202	CbGpPWpGaD
Paricalcitol—Oedema—Doxorubicin—breast cancer	1.99e-05	0.000122	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Methotrexate—breast cancer	1.98e-05	0.000122	CcSEcCtD
Paricalcitol—Fatigue—Methotrexate—breast cancer	1.98e-05	0.000122	CcSEcCtD
Paricalcitol—Infection—Doxorubicin—breast cancer	1.97e-05	0.000121	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—NCOA3—breast cancer	1.97e-05	0.0002	CbGpPWpGaD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	1.97e-05	0.0002	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SLC5A5—breast cancer	1.96e-05	0.000199	CbGpPWpGaD
Paricalcitol—Pain—Methotrexate—breast cancer	1.96e-05	0.000121	CcSEcCtD
Paricalcitol—Vomiting—Capecitabine—breast cancer	1.96e-05	0.00012	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—SLC2A2—breast cancer	1.96e-05	0.000199	CbGpPWpGaD
Paricalcitol—Musculoskeletal discomfort—Epirubicin—breast cancer	1.96e-05	0.00012	CcSEcCtD
Paricalcitol—Shock—Doxorubicin—breast cancer	1.95e-05	0.00012	CcSEcCtD
Paricalcitol—Nervous system disorder—Doxorubicin—breast cancer	1.95e-05	0.00012	CcSEcCtD
Paricalcitol—Rash—Capecitabine—breast cancer	1.94e-05	0.000119	CcSEcCtD
Paricalcitol—Insomnia—Epirubicin—breast cancer	1.94e-05	0.000119	CcSEcCtD
Paricalcitol—Dermatitis—Capecitabine—breast cancer	1.94e-05	0.000119	CcSEcCtD
Paricalcitol—Headache—Capecitabine—breast cancer	1.93e-05	0.000119	CcSEcCtD
Paricalcitol—Skin disorder—Doxorubicin—breast cancer	1.93e-05	0.000119	CcSEcCtD
Paricalcitol—Paraesthesia—Epirubicin—breast cancer	1.93e-05	0.000119	CcSEcCtD
Paricalcitol—VDR—Gene Expression—NOTCH2—breast cancer	1.92e-05	0.000195	CbGpPWpGaD
Paricalcitol—Hyperhidrosis—Doxorubicin—breast cancer	1.92e-05	0.000118	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—MTR—breast cancer	1.92e-05	0.000195	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CPT1A—breast cancer	1.92e-05	0.000195	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ABCG2—breast cancer	1.92e-05	0.000195	CbGpPWpGaD
Paricalcitol—Dyspnoea—Epirubicin—breast cancer	1.91e-05	0.000118	CcSEcCtD
Paricalcitol—Somnolence—Epirubicin—breast cancer	1.91e-05	0.000117	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—SLC2A1—breast cancer	1.9e-05	0.000192	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NQO1—breast cancer	1.9e-05	0.000192	CbGpPWpGaD
Paricalcitol—Anorexia—Doxorubicin—breast cancer	1.89e-05	0.000116	CcSEcCtD
Paricalcitol—Nausea—Docetaxel—breast cancer	1.89e-05	0.000116	CcSEcCtD
Paricalcitol—Feeling abnormal—Methotrexate—breast cancer	1.89e-05	0.000116	CcSEcCtD
Paricalcitol—Dyspepsia—Epirubicin—breast cancer	1.89e-05	0.000116	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—HPGDS—breast cancer	1.88e-05	0.000191	CbGpPWpGaD
Paricalcitol—Gastrointestinal pain—Methotrexate—breast cancer	1.88e-05	0.000115	CcSEcCtD
Paricalcitol—VDR—Gene Expression—NCOA1—breast cancer	1.87e-05	0.00019	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HBA1—breast cancer	1.87e-05	0.00019	CbGpPWpGaD
Paricalcitol—Decreased appetite—Epirubicin—breast cancer	1.87e-05	0.000115	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.86e-05	0.000188	CbGpPWpGaD
Paricalcitol—Hypotension—Doxorubicin—breast cancer	1.86e-05	0.000114	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Epirubicin—breast cancer	1.85e-05	0.000114	CcSEcCtD
Paricalcitol—CYP3A4—Tryptophan metabolism—MDM2—breast cancer	1.85e-05	0.000188	CbGpPWpGaD
Paricalcitol—Fatigue—Epirubicin—breast cancer	1.85e-05	0.000114	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—CYP3A4—breast cancer	1.85e-05	0.000188	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.84e-05	0.000187	CbGpPWpGaD
Paricalcitol—Constipation—Epirubicin—breast cancer	1.84e-05	0.000113	CcSEcCtD
Paricalcitol—Pain—Epirubicin—breast cancer	1.84e-05	0.000113	CcSEcCtD
Paricalcitol—Nausea—Capecitabine—breast cancer	1.83e-05	0.000113	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—GSTT1—breast cancer	1.82e-05	0.000185	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ACHE—breast cancer	1.82e-05	0.000185	CbGpPWpGaD
Paricalcitol—Urticaria—Methotrexate—breast cancer	1.82e-05	0.000112	CcSEcCtD
Paricalcitol—CYP3A4—Biological oxidations—MTR—breast cancer	1.82e-05	0.000185	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CYP1B1—breast cancer	1.82e-05	0.000184	CbGpPWpGaD
Paricalcitol—Abdominal pain—Methotrexate—breast cancer	1.81e-05	0.000111	CcSEcCtD
Paricalcitol—Body temperature increased—Methotrexate—breast cancer	1.81e-05	0.000111	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.81e-05	0.000111	CcSEcCtD
Paricalcitol—Insomnia—Doxorubicin—breast cancer	1.8e-05	0.00011	CcSEcCtD
Paricalcitol—VDR—Gene Expression—AR—breast cancer	1.79e-05	0.000182	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—HPGDS—breast cancer	1.79e-05	0.000181	CbGpPWpGaD
Paricalcitol—Paraesthesia—Doxorubicin—breast cancer	1.78e-05	0.00011	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—HSP90AA1—breast cancer	1.78e-05	0.000181	CbGpPWpGaD
Paricalcitol—Dyspnoea—Doxorubicin—breast cancer	1.77e-05	0.000109	CcSEcCtD
Paricalcitol—Feeling abnormal—Epirubicin—breast cancer	1.77e-05	0.000109	CcSEcCtD
Paricalcitol—Somnolence—Doxorubicin—breast cancer	1.77e-05	0.000109	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Epirubicin—breast cancer	1.75e-05	0.000108	CcSEcCtD
Paricalcitol—Dyspepsia—Doxorubicin—breast cancer	1.75e-05	0.000108	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—NCOA1—breast cancer	1.73e-05	0.000176	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—GSTT1—breast cancer	1.73e-05	0.000176	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP17A1—breast cancer	1.73e-05	0.000175	CbGpPWpGaD
Paricalcitol—Decreased appetite—Doxorubicin—breast cancer	1.73e-05	0.000106	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Doxorubicin—breast cancer	1.71e-05	0.000105	CcSEcCtD
Paricalcitol—Fatigue—Doxorubicin—breast cancer	1.71e-05	0.000105	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—STK11—breast cancer	1.71e-05	0.000173	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CYP19A1—breast cancer	1.71e-05	0.000173	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ENO1—breast cancer	1.71e-05	0.000173	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PTGS1—breast cancer	1.71e-05	0.000173	CbGpPWpGaD
Paricalcitol—Urticaria—Epirubicin—breast cancer	1.7e-05	0.000105	CcSEcCtD
Paricalcitol—Constipation—Doxorubicin—breast cancer	1.7e-05	0.000104	CcSEcCtD
Paricalcitol—Pain—Doxorubicin—breast cancer	1.7e-05	0.000104	CcSEcCtD
Paricalcitol—Body temperature increased—Epirubicin—breast cancer	1.7e-05	0.000104	CcSEcCtD
Paricalcitol—Abdominal pain—Epirubicin—breast cancer	1.7e-05	0.000104	CcSEcCtD
Paricalcitol—Hypersensitivity—Methotrexate—breast cancer	1.69e-05	0.000104	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—CYP2D6—breast cancer	1.68e-05	0.00017	CbGpPWpGaD
Paricalcitol—Asthenia—Methotrexate—breast cancer	1.65e-05	0.000101	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—NCOA2—breast cancer	1.65e-05	0.000167	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP17A1—breast cancer	1.64e-05	0.000166	CbGpPWpGaD
Paricalcitol—Feeling abnormal—Doxorubicin—breast cancer	1.64e-05	0.000101	CcSEcCtD
Paricalcitol—VDR—Gene Expression—SIRT1—breast cancer	1.63e-05	0.000166	CbGpPWpGaD
Paricalcitol—Gastrointestinal pain—Doxorubicin—breast cancer	1.62e-05	9.99e-05	CcSEcCtD
Paricalcitol—CYP3A4—Biological oxidations—PTGS1—breast cancer	1.62e-05	0.000165	CbGpPWpGaD
Paricalcitol—Pruritus—Methotrexate—breast cancer	1.62e-05	9.98e-05	CcSEcCtD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP17A1—breast cancer	1.62e-05	0.000164	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—SMAD4—breast cancer	1.61e-05	0.000164	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.6e-05	0.000163	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—FASN—breast cancer	1.6e-05	0.000162	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP2D6—breast cancer	1.59e-05	0.000161	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—COMT—breast cancer	1.59e-05	0.000161	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—BCHE—breast cancer	1.59e-05	0.000161	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GSTP1—breast cancer	1.58e-05	0.00016	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Epirubicin—breast cancer	1.58e-05	9.72e-05	CcSEcCtD
Paricalcitol—Urticaria—Doxorubicin—breast cancer	1.58e-05	9.7e-05	CcSEcCtD
Paricalcitol—Abdominal pain—Doxorubicin—breast cancer	1.57e-05	9.65e-05	CcSEcCtD
Paricalcitol—Body temperature increased—Doxorubicin—breast cancer	1.57e-05	9.65e-05	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—SLC5A5—breast cancer	1.57e-05	0.000159	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP2D6—breast cancer	1.57e-05	0.000159	CbGpPWpGaD
Paricalcitol—Diarrhoea—Methotrexate—breast cancer	1.57e-05	9.65e-05	CcSEcCtD
Paricalcitol—VDR—Gene Expression—NCOR1—breast cancer	1.57e-05	0.000159	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—NCOA2—breast cancer	1.56e-05	0.000158	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—HMOX1—breast cancer	1.56e-05	0.000158	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ITPR1—breast cancer	1.56e-05	0.000158	CbGpPWpGaD
Paricalcitol—Asthenia—Epirubicin—breast cancer	1.54e-05	9.47e-05	CcSEcCtD
Paricalcitol—VDR—Gene Expression—H2AFX—breast cancer	1.53e-05	0.000155	CbGpPWpGaD
Paricalcitol—Pruritus—Epirubicin—breast cancer	1.52e-05	9.34e-05	CcSEcCtD
Paricalcitol—Dizziness—Methotrexate—breast cancer	1.52e-05	9.33e-05	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—SLC2A1—breast cancer	1.52e-05	0.000154	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NQO1—breast cancer	1.52e-05	0.000154	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ABCB1—breast cancer	1.5e-05	0.000152	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP3A4—breast cancer	1.48e-05	0.00015	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—ERCC2—breast cancer	1.47e-05	0.000149	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—TYMS—breast cancer	1.47e-05	0.000149	CbGpPWpGaD
Paricalcitol—Diarrhoea—Epirubicin—breast cancer	1.47e-05	9.03e-05	CcSEcCtD
Paricalcitol—Hypersensitivity—Doxorubicin—breast cancer	1.46e-05	9e-05	CcSEcCtD
Paricalcitol—Vomiting—Methotrexate—breast cancer	1.46e-05	8.97e-05	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—CYP1B1—breast cancer	1.45e-05	0.000147	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GSTM1—breast cancer	1.45e-05	0.000147	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PLA2G4A—breast cancer	1.45e-05	0.000147	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NCOR1—breast cancer	1.45e-05	0.000147	CbGpPWpGaD
Paricalcitol—Rash—Methotrexate—breast cancer	1.45e-05	8.89e-05	CcSEcCtD
Paricalcitol—Dermatitis—Methotrexate—breast cancer	1.44e-05	8.88e-05	CcSEcCtD
Paricalcitol—Headache—Methotrexate—breast cancer	1.44e-05	8.84e-05	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—HSP90AA1—breast cancer	1.43e-05	0.000145	CbGpPWpGaD
Paricalcitol—Asthenia—Doxorubicin—breast cancer	1.42e-05	8.76e-05	CcSEcCtD
Paricalcitol—Dizziness—Epirubicin—breast cancer	1.42e-05	8.73e-05	CcSEcCtD
Paricalcitol—Pruritus—Doxorubicin—breast cancer	1.4e-05	8.64e-05	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—GPX1—breast cancer	1.39e-05	0.000141	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NCOA1—breast cancer	1.39e-05	0.000141	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP1B1—breast cancer	1.38e-05	0.00014	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CYP1A1—breast cancer	1.38e-05	0.00014	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—STK11—breast cancer	1.37e-05	0.000139	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ERCC2—breast cancer	1.37e-05	0.000139	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP19A1—breast cancer	1.37e-05	0.000139	CbGpPWpGaD
Paricalcitol—Vomiting—Epirubicin—breast cancer	1.36e-05	8.39e-05	CcSEcCtD
Paricalcitol—Nausea—Methotrexate—breast cancer	1.36e-05	8.38e-05	CcSEcCtD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP1B1—breast cancer	1.36e-05	0.000138	CbGpPWpGaD
Paricalcitol—Diarrhoea—Doxorubicin—breast cancer	1.36e-05	8.36e-05	CcSEcCtD
Paricalcitol—Rash—Epirubicin—breast cancer	1.35e-05	8.32e-05	CcSEcCtD
Paricalcitol—Dermatitis—Epirubicin—breast cancer	1.35e-05	8.31e-05	CcSEcCtD
Paricalcitol—Headache—Epirubicin—breast cancer	1.34e-05	8.27e-05	CcSEcCtD
Paricalcitol—VDR—Generic Transcription Pathway—MYC—breast cancer	1.33e-05	0.000135	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—NCOA1—breast cancer	1.32e-05	0.000133	CbGpPWpGaD
Paricalcitol—Dizziness—Doxorubicin—breast cancer	1.31e-05	8.08e-05	CcSEcCtD
Paricalcitol—CYP3A4—Biological oxidations—CYP19A1—breast cancer	1.3e-05	0.000132	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—MTHFR—breast cancer	1.28e-05	0.00013	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	1.28e-05	0.00013	CbGpPWpGaD
Paricalcitol—Nausea—Epirubicin—breast cancer	1.27e-05	7.84e-05	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—COMT—breast cancer	1.27e-05	0.000129	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GSTP1—breast cancer	1.26e-05	0.000128	CbGpPWpGaD
Paricalcitol—Vomiting—Doxorubicin—breast cancer	1.26e-05	7.77e-05	CcSEcCtD
Paricalcitol—Rash—Doxorubicin—breast cancer	1.25e-05	7.7e-05	CcSEcCtD
Paricalcitol—Dermatitis—Doxorubicin—breast cancer	1.25e-05	7.69e-05	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—HMOX1—breast cancer	1.25e-05	0.000126	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ITPR1—breast cancer	1.24e-05	0.000126	CbGpPWpGaD
Paricalcitol—Headache—Doxorubicin—breast cancer	1.24e-05	7.65e-05	CcSEcCtD
Paricalcitol—VDR—Gene Expression—ESR1—breast cancer	1.23e-05	0.000125	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—COMT—breast cancer	1.21e-05	0.000122	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—GSTP1—breast cancer	1.2e-05	0.000122	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ABCB1—breast cancer	1.2e-05	0.000121	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—NOTCH1—breast cancer	1.19e-05	0.000121	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—COMT—breast cancer	1.19e-05	0.000121	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CAV1—breast cancer	1.18e-05	0.00012	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	1.18e-05	0.00012	CbGpPWpGaD
Paricalcitol—Nausea—Doxorubicin—breast cancer	1.18e-05	7.25e-05	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—TYMS—breast cancer	1.18e-05	0.000119	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PLA2G4A—breast cancer	1.16e-05	0.000118	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GSTM1—breast cancer	1.16e-05	0.000118	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NCOR1—breast cancer	1.16e-05	0.000118	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.13e-05	0.000115	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GPX1—breast cancer	1.11e-05	0.000113	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—GSTM1—breast cancer	1.1e-05	0.000112	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CYP1A1—breast cancer	1.1e-05	0.000112	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ERCC2—breast cancer	1.09e-05	0.000111	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	1.09e-05	0.00011	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PIK3CG—breast cancer	1.08e-05	0.000109	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP1A1—breast cancer	1.05e-05	0.000106	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	1.03e-05	0.000105	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—MTHFR—breast cancer	1.03e-05	0.000104	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—SERPINE1—breast cancer	1.01e-05	0.000103	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PIK3CD—breast cancer	9.49e-06	9.62e-05	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CAV1—breast cancer	9.47e-06	9.61e-05	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ALB—breast cancer	9.37e-06	9.5e-05	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NOS3—breast cancer	8.96e-06	9.09e-05	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PIK3CG—breast cancer	8.63e-06	8.75e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SYNJ2—breast cancer	8.41e-06	8.53e-05	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PIK3CB—breast cancer	8.27e-06	8.39e-05	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PTGS2—breast cancer	8.19e-06	8.31e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NDUFS3—breast cancer	7.82e-06	7.93e-05	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PIK3CD—breast cancer	7.58e-06	7.69e-05	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALB—breast cancer	7.49e-06	7.59e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CHST9—breast cancer	7.35e-06	7.46e-05	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NOS3—breast cancer	7.16e-06	7.26e-05	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PTEN—breast cancer	7.15e-06	7.25e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—COX11—breast cancer	6.97e-06	7.07e-05	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PIK3CB—breast cancer	6.61e-06	6.71e-05	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—MAPK3—breast cancer	6.58e-06	6.67e-05	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PTGS2—breast cancer	6.55e-06	6.64e-05	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—MYC—breast cancer	6.4e-06	6.49e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SHMT1—breast cancer	6.37e-06	6.47e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CDA—breast cancer	6.37e-06	6.47e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SLC2A5—breast cancer	6.14e-06	6.22e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SLCO1B1—breast cancer	6.14e-06	6.22e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—APRT—breast cancer	5.93e-06	6.01e-05	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PTEN—breast cancer	5.71e-06	5.79e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ESRRA—breast cancer	5.57e-06	5.65e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ANGPTL4—breast cancer	5.57e-06	5.65e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GPI—breast cancer	5.28e-06	5.36e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HADHB—breast cancer	5.28e-06	5.36e-05	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PIK3CA—breast cancer	5.04e-06	5.11e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALDH7A1—breast cancer	5.04e-06	5.11e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALDH1A1—breast cancer	5.04e-06	5.11e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NME1—breast cancer	4.83e-06	4.9e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—FHL2—breast cancer	4.83e-06	4.9e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ADSL—breast cancer	4.83e-06	4.9e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—UMPS—breast cancer	4.83e-06	4.9e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PHGDH—breast cancer	4.83e-06	4.9e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HPSE—breast cancer	4.74e-06	4.81e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—BRIP1—breast cancer	4.74e-06	4.81e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—LDHB—breast cancer	4.74e-06	4.81e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTA3—breast cancer	4.49e-06	4.56e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HMMR—breast cancer	4.49e-06	4.56e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ABCC1—breast cancer	4.49e-06	4.56e-05	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—AKT1—breast cancer	4.44e-06	4.5e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PPARGC1B—breast cancer	4.35e-06	4.41e-05	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—AKT1—breast cancer	4.12e-06	4.18e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTA4—breast cancer	4.11e-06	4.17e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CA9—breast cancer	4.11e-06	4.17e-05	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PIK3CA—breast cancer	4.03e-06	4.09e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTA2—breast cancer	4e-06	4.06e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GPX2—breast cancer	4e-06	4.06e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SULT1A1—breast cancer	3.95e-06	4.01e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GPX4—breast cancer	3.95e-06	4.01e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—IDH1—breast cancer	3.86e-06	3.92e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTA1—breast cancer	3.86e-06	3.92e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NAT2—breast cancer	3.82e-06	3.87e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—DPYD—breast cancer	3.35e-06	3.4e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—MED12—breast cancer	3.35e-06	3.4e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALDOA—breast cancer	3.3e-06	3.34e-05	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—AKT1—breast cancer	3.29e-06	3.34e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NCOA3—breast cancer	3.2e-06	3.25e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SLC2A2—breast cancer	3.18e-06	3.22e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—MTR—breast cancer	3.11e-06	3.16e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ABCG2—breast cancer	3.11e-06	3.16e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CPT1A—breast cancer	3.11e-06	3.16e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HPGDS—breast cancer	3.05e-06	3.1e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HBA1—breast cancer	3.03e-06	3.08e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTT1—breast cancer	2.96e-06	3e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ACHE—breast cancer	2.96e-06	3e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP17A1—breast cancer	2.8e-06	2.84e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ENO1—breast cancer	2.77e-06	2.81e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PTGS1—breast cancer	2.77e-06	2.81e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP2D6—breast cancer	2.72e-06	2.76e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NCOA2—breast cancer	2.67e-06	2.71e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—FASN—breast cancer	2.59e-06	2.63e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—BCHE—breast cancer	2.58e-06	2.62e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SLC5A5—breast cancer	2.55e-06	2.58e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SLC2A1—breast cancer	2.46e-06	2.5e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NQO1—breast cancer	2.46e-06	2.5e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP1B1—breast cancer	2.36e-06	2.39e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.31e-06	2.35e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NCOA1—breast cancer	2.25e-06	2.28e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—STK11—breast cancer	2.22e-06	2.25e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP19A1—breast cancer	2.22e-06	2.25e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—COMT—breast cancer	2.06e-06	2.09e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTP1—breast cancer	2.05e-06	2.08e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HMOX1—breast cancer	2.02e-06	2.05e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ITPR1—breast cancer	2.02e-06	2.05e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ABCB1—breast cancer	1.94e-06	1.97e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—TYMS—breast cancer	1.91e-06	1.94e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.89e-06	1.91e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NCOR1—breast cancer	1.89e-06	1.91e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTM1—breast cancer	1.89e-06	1.91e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GPX1—breast cancer	1.81e-06	1.83e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP1A1—breast cancer	1.79e-06	1.81e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ERCC2—breast cancer	1.77e-06	1.8e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—MTHFR—breast cancer	1.67e-06	1.69e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CAV1—breast cancer	1.54e-06	1.56e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PIK3CG—breast cancer	1.4e-06	1.42e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PIK3CD—breast cancer	1.23e-06	1.25e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALB—breast cancer	1.22e-06	1.23e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NOS3—breast cancer	1.16e-06	1.18e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PIK3CB—breast cancer	1.07e-06	1.09e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PTGS2—breast cancer	1.06e-06	1.08e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PTEN—breast cancer	9.27e-07	9.41e-06	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PIK3CA—breast cancer	6.54e-07	6.64e-06	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AKT1—breast cancer	5.34e-07	5.42e-06	CbGpPWpGaD
